Neurofibromatosis-Noonan Syndrome
An overlap of neurofibromatosis type 1 and Noonan syndrome
Quick Facts
- Type: Rare inherited genetic condition
- Gene usually involved: NF1
- Combines features of: Neurofibromatosis type 1 and Noonan syndrome
- Care: Coordinated, multispecialty follow-up
Overview
Neurofibromatosis-Noonan syndrome is a rare genetic condition in which a person has features of both neurofibromatosis type 1 (NF1) and Noonan syndrome at the same time. NF1 is associated with cafe-au-lait spots, freckling, and benign nerve tumors, while Noonan syndrome involves distinctive facial features, short stature, and certain heart differences. In this overlap condition, elements of both appear together.
Most cases are linked to changes in the NF1 gene, the same gene responsible for classic NF1, which is why the conditions overlap. Because the combination of features can affect several body systems, care is usually shared among a number of specialists, and the exact mix and severity of features varies considerably from person to person.
Symptoms
People with this condition can show a blend of NF1 and Noonan features. These may include:
- Cafe-au-lait spots and freckling in skin folds
- Benign nerve tumors (neurofibromas)
- Distinctive facial features, such as widely spaced eyes or a broad forehead
- Short stature
- A webbed or short neck
- Heart differences, including pulmonary valve narrowing
- Learning or developmental differences in some people
Not everyone has all of these features, and the severity ranges from mild to more significant. The particular combination is what distinguishes the condition from NF1 or Noonan syndrome alone.
Causes
Neurofibromatosis-Noonan syndrome is usually caused by changes (variants) in the NF1 gene, which normally helps control cell growth and the development of several body systems. The way the gene change affects the body produces a mix of NF1 and Noonan-type features.
- Inherited: The condition can follow an autosomal dominant pattern, meaning a child of an affected parent has a 50 percent chance of inheriting it.
- New gene change: It can also arise as a new change in someone with no family history.
- Genetic overlap: Because NF1 and Noonan syndrome involve related signaling pathways, features can blend in this condition.
Risk Factors
- Having a parent with neurofibromatosis type 1 or this overlap condition
- A family history of NF1 features combined with Noonan-type features
- Being evaluated for NF1 and found to have additional Noonan-like features
Diagnosis
Diagnosis relies on recognizing the combined features and confirming the genetic cause:
- Clinical examination: Identifying both NF1 features (cafe-au-lait spots, freckling, neurofibromas) and Noonan features (facial appearance, short stature, neck differences).
- Heart assessment: An echocardiogram to check for valve narrowing or other heart differences.
- Genetic testing: Testing the NF1 gene, and sometimes related genes, to confirm the diagnosis.
- Developmental evaluation: Assessing learning and development.
Treatment
There is no cure for the underlying genetic condition, so care manages each feature as needed:
- Heart care: Monitoring or treating valve narrowing and other heart differences with a cardiologist.
- Tumor management: Watching benign nerve tumors and treating any that cause symptoms.
- Growth and developmental support: Help for short stature and learning differences where appropriate.
- Skin care: Cafe-au-lait spots are harmless and need no treatment.
- Multispecialty follow-up: Coordinated care across genetics, cardiology, neurology, and developmental specialists.
- Genetic counseling: Helping families understand inheritance and recurrence chances.
Prevention
This condition cannot be prevented because it is caused by a genetic change. Useful steps include:
- Genetic counseling for affected families
- Early heart evaluation and ongoing cardiac follow-up
- Monitoring of nerve tumors so any change is caught early
- Early developmental support for children
When to See a Doctor
See a doctor if you or your child has:
- A combination of cafe-au-lait spots, nerve tumors, and Noonan-type features
- A heart murmur, breathlessness, or poor exercise tolerance
- A known nerve tumor that grows quickly or develops new constant pain
- Growth or developmental concerns
Seek prompt medical attention for new or worsening breathlessness, chest pain, fainting, or a bluish color, which can indicate a heart problem that needs urgent assessment.
Frequently Asked Questions
What is neurofibromatosis-Noonan syndrome?
It is a rare genetic condition in which a person has features of both neurofibromatosis type 1 and Noonan syndrome at once, such as cafe-au-lait spots and nerve tumors together with distinctive facial features, short stature, and heart differences.
What causes this condition?
It is usually caused by changes in the NF1 gene, the same gene involved in classic neurofibromatosis type 1. Because NF1 and Noonan syndrome involve related signaling pathways, features from both can blend in this condition.
Is neurofibromatosis-Noonan syndrome inherited?
It can be inherited in an autosomal dominant pattern, so a child of an affected parent has a 50 percent chance of inheriting it, but it can also arise as a new gene change. Genetic counseling helps families understand their situation.
How is it treated?
There is no cure, so treatment manages individual features: monitoring or treating heart valve narrowing, watching nerve tumors and treating symptomatic ones, and supporting growth and learning. Care is usually shared among several specialists.
When are heart symptoms urgent?
Seek prompt medical care for new or worsening breathlessness, chest pain, fainting, or a bluish color. These can indicate that a heart difference such as valve narrowing needs urgent evaluation.
References
- National Organization for Rare Disorders (NORD). Noonan Syndrome.
- Genetic and Rare Diseases Information Center (GARD). Neurofibromatosis-Noonan syndrome.
- National Institute of Neurological Disorders and Stroke (NINDS). Neurofibromatosis.
- MedlinePlus, U.S. National Library of Medicine. Neurofibromatosis 1.